TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis Front. 12 September 2018.

Epilepsy 72

Epilepsy Extraction Treatment CBD 72

TheAnswerPage

JUNE 21, 2022

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition?

Epilepsy 52

Epilepsy Cannabinoids Medicine Conditions 52

TheAnswerPage

MAY 25, 2022

The results of recent clinical trials indicate that Cannabidiol (CBD) reduces seizures among patients with refractory epilepsies of various etiologies. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy. Most of these clinical studies report efficacy over short time periods (. Skirvin, Christina Wade.

Clinical Trials 52

Clinical Trials Epilepsy Treatment CBD 52

TheAnswerPage

MAY 16, 2022

According to a presentation at the 2014 annual meeting of the American Epilepsy Society, an increasing dose of CBD was associated with significant increases in serum levels of topiramate, rufinamide, and N-desmethylclobazam. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

Epilepsy 52

Epilepsy Programs Treatment CBD 52

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 52

Epilepsy Therapy Extraction Data 52

TheAnswerPage

JUNE 27, 2022

of epilepsy? Some registered trials are currently examining the efficacy of 3:1 THC:CBD, (ClinicalTrials.gov Identifier: NCT04042545) in cancer pain and 1:20 THC:CBD (ClinicalTrials.gov Identifier:NCT03024827) in epilepsy. What is the most effective combination of THC to CBD in the treatment of cancer pain? Schlag, A.K., O’Sullivan, S.E,

Epilepsy 52

Epilepsy Treatment THC CBD 52

TheAnswerPage

JULY 18, 2022

In 2017, researchers performed an analysis of observational studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products and reported on the side effects of the CBD products: “The reports of mild (158/216, 76% vs. 148/447, 33%, p. Pamplona F, da Silva L and Coan A.

Epilepsy 52

Epilepsy Therapy Extraction Treatment 52

TheAnswerPage

AUGUST 8, 2022

Currently, CBD-containing gels are being evaluated for the treatment of several pediatric disorders, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See the Answer.

Epilepsy 59

Epilepsy Topical Treatment CBD 59

TheAnswerPage

DECEMBER 31, 2021

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition?

Epilepsy 52

Epilepsy Cannabinoids Medicine Conditions 52

TheAnswerPage

MAY 9, 2022

Currently, CBD-containing gels are being evaluated for the treatment of several pediatric disorders, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See the Answer.

Epilepsy 59

Epilepsy Topical Treatment CBD 59

TheAnswerPage

JANUARY 6, 2022

of epilepsy? Some registered trials are currently examining the efficacy of 3:1 THC:CBD, (ClinicalTrials.gov Identifier: NCT04042545) in cancer pain and 1:20 THC:CBD (ClinicalTrials.gov Identifier:NCT03024827) in epilepsy. What is the most effective combination of THC to CBD in the treatment of cancer pain? Schlag, A.K., O’Sullivan, S.E,

Epilepsy 52

Epilepsy Treatment THC CBD 52

TheAnswerPage

MAY 6, 2022

American Epilepsy Society (AES): Written Comments to Norman E. Epilepsy Currents 2019; 19(6):361-368. The inhibition of CYP2C19 by CBD can increase levels of warfarin, and multiple reports have indicated that the interaction between warfarin and CBD results in an increased risk of bleeding. Treese NM, Flowers M. 2020; 45(3):20-23.

Epilepsy 52

Epilepsy Food Data Oil 52

TheAnswerPage

JUNE 29, 2022

Yes, GW Pharmaceuticals (the makers of Epidiolex) had trialed CBDV in adult epilepsy, but the study did not meet its primary endpoint of seizure reduction. Has CBDV been evaluated as an anti-seizure medication in clinical trials? That trial did not continue.

Clinical Trials 59

Clinical Trials Epilepsy Pharmaceutical Treatment 59

TheAnswerPage

FEBRUARY 8, 2022

Epilepsy Behav. No, not according to a 2020 clinical trial which involved the abrupt withdrawal of CBD after four-weeks of use (750 mg twice daily taken orally). Crockett, J., Checketts, D., Sommerville, K., Abrupt withdrawal of cannabidiol (CBD): a randomized trial. 104, 106938. See the Answer.

Clinical Trials 59

Clinical Trials Epilepsy CBD 59

TheAnswerPage

JUNE 15, 2022

It is approved to treat rare, severe pediatric epilepsy disorders. These products are sold in grocery stores, specialty stores, and convenience stores across the US and on the internet. However, only one prescription CBD product has been approved by the FDA. It is called Epidiolex. See the Answer.

Pets 59

Pets Epilepsy Topical Oil 59

TheAnswerPage

JANUARY 9, 2022

Yes, GW Pharmaceuticals (the makers of Epidiolex) had trialed CBDV in adult epilepsy, but the study did not meet its primary endpoint of seizure reduction. Has CBDV been evaluated as an anti-seizure medication in clinical trials? That trial did not continue.

Clinical Trials 59

Clinical Trials Epilepsy Pharmaceutical Treatment 59

TheAnswerPage

MAY 10, 2022

The FDA has approved a CBD product (Epidiolex) for the treatment of 3 rare forms of epilepsy. What is the mechanism of action of CBD in this anti-epileptic medication? How does CBD exert its anti-convulsant effects?

Epilepsy 52

Epilepsy Treatment Cannabinoids CBD 52

LifeCannMD

JANUARY 2, 2024

Florida Epilepsy Patients : CBD blocks the ability of LPI to amplify nerve signals in a brain region and has been known to reduce the frequency and severity of seizures in epilepsy. Some animal-based studies go as far as to suggest cannabinoids might slow cancer cell growth.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

TheAnswerPage

MAY 20, 2022

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy?

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

The Cannigma

JULY 12, 2022

Roll out of the program has been slow, and as of June 2022, there were still no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products. As of June 2022, there is no way for medical patients to obtain a cannabis prescription or get medication. Possible penalties for cannabis.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

The Cannigma

SEPTEMBER 15, 2022

Despite overwhelming support from state residents ( 81% of residents think cannabis should be legal in some capacity) multiple bills in 2022 and 2021 to legalize medical marijuana have failed. The state does allow qualifying patients to access CBD oil with no more than 0.9% THC, which is higher than the 0.3% federal standard for CBD oil.

Law 89

Law Oil Programs Hemp 89

The Cannigma

JUNE 25, 2022

Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Up until 2022, no cannabis was grown in Poland so all products had to be imported, which led to massive delays in patients being able to access medication. Is CBD legal in Poland?

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Cannabis Law Report

AUGUST 31, 2021

Alixen™ 30 will target indications such as anxiety, insomnia, Parkinson’s Disease, and depression, while Alixen™ 100 will be used in the treatment of epilepsy. The Company also expects to have finished THC products available for commercial distribution in early 2022 to address additional pathologies, including chronic pain.

Chronic Pain 105

Chronic Pain Epilepsy THC Patients 105

The Joint Blog

MAY 24, 2022

It also helps with inflammation and other physical ailments like arthritis and neurological disorders such as epilepsy, cancer, etc. The post 5 Best CBD Products For Pets In 2022 appeared first on The Joint Blog. Here, we discuss five of the best CBD products today for your furry friends.

Pets 26

Pets CBD Tincture Oil 26

The Joint Blog

FEBRUARY 24, 2022

recognized the product as a medical drug to cure post-traumatic stress disorder, epilepsy, chronic pain, arthritis, and Alzheimer’s disease. The post Biggest Business Challenges for the Cannabis Industry in 2022 appeared first on The Joint Blog. The District of Columbia and Eleven states legalized the adoption of the product in 2019.

Business 26

Business Research and Development Chronic Pain Policy 26

The Cannigma

SEPTEMBER 8, 2022

In the 2022 legislative session, there were two cannabis bills introduced: one would decriminalize possession of up to three ounces of cannabis and the other would create a medical cannabis program, however, these are not expected to see movement until 2023 at the earliest. Cannabis in Wyoming.

Law 75

Law Supply Chain Programs Concentrates 75

The Cannigma

JULY 5, 2022

But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. Despite having 20,000 registered patients in March of 2022, there are no licensed producers or distributors of cannabis products and sales are unlikely to start before mid-2023 at the earliest.

Law 96

Law Decriminalization Programs Patients 96

Cannabis Law Report

APRIL 20, 2022

20 Apr, 2022, 01:41 IDT. WROCLAW, Poland , April 19, 2022 /PRNewswire/ — Can4Med , a licensed wholesale specializing in medical products containing THC and cannabinoids has obtained Polish authorization to supply medical products and raw materials for cannabis pharmaceutical sales.

Pharmaceutical 52

Pharmaceutical Patients Medicine Epilepsy 52

MedicalJane

OCTOBER 19, 2022

As of February 2022, Pennsylvania is one of 37 states (plus Washington D.C.) Pennsylvania’s Medical Marijuana Program, or “The Compassionate Use of Medical Cannabis Act (SB3),” allows people with specific medical conditions to use and purchase medical marijuana without having to worry about legal consequences. HIV / AIDS.

Marijuana 99

Marijuana Therapy Programs Patients 99

Veriheal

MARCH 6, 2024

The HSS also pointed out studies with weaker evidence suggesting cannabis can potentially help with conditions like PTSD , epilepsy , and anxiety. As Oregon-based research firm Whitney Economics highlighted, in 2022 state-legal cannabis businesses paid more than $1.8 billion in excess taxes when compared to non-cannabis businesses.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

The Cannigma

DECEMBER 24, 2022

In March 2022, a cannabis museum opened Zagreb. The proposal had yet to pass in 2022. Qualifying conditions include: Cancer AIDS Multiple sclerosis Pediatric epilepsy. While recreational cannabis remains illegal, attitudes are changing. Possible penalties. grams per month.

Law 59

Law Decriminalization Cultivation Recreational 59

Cannabis Law Report

AUGUST 12, 2021

Szaflarski, director of the UAB Epilepsy Center in the Department of Neurology and a lead investigator in the UAB study on the use of CBD oil to treat seizure disorders, a program authorized by the passing of Carly’s Law in 2014. The panel faces several deadlines to set up the rules to launch what will be a fully intrastate program.

Programs 105

Programs Seed-To-Sale Agriculture Legislation 105

The Cannigma

NOVEMBER 3, 2022

Patients with qualifying conditions, including cancer, multiple sclerosis, epilepsy, and HIV/AIDS can access cannabis-derived medicines with a prescription. As of July 2022, at least one publication reported no patients have access to cannabis medicine.

Law 59

Law Decriminalization Programs Hemp 59

Cannabis Law Report

AUGUST 12, 2022

But Chung said there is a lack of concrete evidence of its benefits, and that most places that have legalized CBD medication use them only for rare medical conditions, such as severe forms of epilepsy. When the ban was discussed on June 7, authorities said they intended “to table the relevant legislation within 2022.”

CBD 98

CBD THC Epilepsy Sleep 98

NewsMunchies

MAY 8, 2023

By 2021, advocates had two separate campaigns to bring full legalization to the ballot in 2022. The ballot measure permitting medical cannabis won with 71 percent support. But the state Supreme Court killed both measures, stating that they violated the constitution by using “misleading” language.

Law 81

Law Marijuana Conditions Epilepsy 81

Otherside Farms

MAY 12, 2022

Full spectrum distillate is being used to treat anything from muscular pains and anxiety to arthritis, epilepsy, and PTSD. We have every reason to anticipate that cannabis will accelerate favourably in 2022, with every sector of the business working to bring it ahead, from consumers and producers to distributors and shops.

Extraction 98

Extraction Cannabinoids Hemp Epilepsy 98